Finasteride Market Forecasts to 2028 – Global Analysis By Application (Prostate Treatment, Hair Treatment, Medical Uses, Benign Prostatic Hyperplasia, Male Pattern Baldness), Product (1 mg Tablet, 5 mg Tablet) and By Geography
According to Stratistics MRC, the Global Finasteride Market is accounted for $112.75 million in 2020 and is expected to reach $160.34 million by 2028 growing at a CAGR of 4.5% during the forecast period. Rising cases of prostate cancer, and growing consumers spending on hair care products, are driving the market growth. However, possible side effects associated with the finasteride tablets hampers the growth of the market.
Finasteride serves as an active ingredient in manufacturing drugs for controlling baldness and prostate cancer in men. The products improve BPH symptoms and decrease the urge for urine and contribute to better urinating flow with less strain. The active ingredient works to decrease natural body hormone (DHT), which serves as the main factor for prostate growth.
Based on the product, the 1 mg tablet segment is going to have lucrative growth during the forecast period as 1mg products are 5-alpha reductase inhibitor which blocks body production of a male hormone that reduces hair loss in the scalp. Finasteride products are very effective and low cost, thereby stimulates finasteride market size. Growing demand for quick remedy pharma drugs for treating baldness and hair loss using 1mg tablet will further propel the finasteride market.
By geography, Europe is going to have high growth during the forecast period as Europe is at the highest risk of suffering from bald-headedness and the figures are expected to ascend rapidly in the forthcoming years. Moreover, the treatment for Alopecia and increased hair loss problems due to ageing is expected to grow significantly over the forecast timeframe which will support the finasteride market in this region.
Some of the key players profiled in the Finasteride Market include Dr. Reddy's Laboratories, Zhejiang CONBA Pharmaceutical Co., Ltd., Teva Pharmaceuticals , Novartis, Accord Healthcare, Actavis, Cipla, Relonchem Limited, Merck and Henan Topfond Pharmaceutical Co., Ltd.
• Prostate Treatment
• Hair Treatment
• Medical Uses
• Benign Prostatic Hyperplasia
• Male Pattern Baldness
• 1 mg Tablet
• 5 mg Tablet
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.